Education and Training
Maria Espinosa, MD
Dr. Espinosa is an academically accomplished dermatologist that specializes in medical, surgical, and cosmetic dermatology, caring for patients of all ages. Graduating magna cum laude from Ohio State University with a Bachelor of Science in Neuroscience, she went on to complete a research year in Cutaneous Lymphoma at Northwestern University, Department of Dermatology. She then earned her medical degree from the University of Chicago, Pritzker School of Medicine. Her commitment to excellence continued during her transitional year and dermatology residency at Henry Ford Health, Medicine Department of Dermatology where she served as chief resident.
Dr. Espinosa’s clinical interests include general and complex medical conditions such as annual skin cancer screening, acne, rosacea, eczema, psoriasis as well as more complex autoimmune disorders. Dr. Espinosa is also skilled in performing surgical procedures on skin cancers and cysts, and cosmetic enhancements like Botox, laser treatments, and chemical peels.
Dr. Espinosa values creating personalized treatment plans and ensuring each patient feels heard and cared for. She is fluent in English and Spanish, allowing her to connect with a diverse group of patients. Her goal is to build lasting relationships and help patients achieve healthy, confident skin.
Outside of work, Dr. Espinosa loves spending time with her husband, Kevin, and their mini Goldendoodle, Louie.
1. Singh I, Espinosa ML, Lim HW, Mohammad TF. A review of therapies for hyperpigmentation modulating the synthesis of eumelanin to pheomelanin. Archives of Dermatology. Arch Dermatol Res. 2024 Oct 9;316(9):668. doi: 10.1007/s00403-024-03411-4.
2. LeWitt TM, Walker CJ, Espinosa ML, Chung C, Zhou XA, Guitart J. Reply to letter to the editor (Manuscript # JAAD-D-22-03011R1). J Am Acad Dermatol. 2023 Jul;89(1):e67. doi: 10.1016/j.jaad.2023.02.056.
3. Nguyen M, LeWitt T, Pang Y, Bagnowski K, Espinosa ML, Choi J, Guitart J, Liszewski W, Zhou XA. Lifestyle, demographic and Skindex measures associated with cutaneous T-cell lymphoma: a single institution cohort study. Arch Dermatol Res. 2023 Mar;315(2):275-278. doi: 10.1007/s00403-022-02360-0.
4. Chung C, Espinosa ML, Walker CJ, Choi J, Zhou XA, LeWitt T, Liszewski W, Guitart J. Acceleration of skin involvement may predict disease progression in early-stage mycosis fungoides: A retrospective cohort study. J Am Acad Dermatol. 2022 Nov;87(5):1140-1141. doi: 10.1016/j.jaad.2022.02.015.
5. Guitart J, Mangold AR, Martinez-Escala ME, Walker CJ, Comfere NI, Pulitzer M, Rieger KE, Torres-Cabala CA, Pincus LB, Kumar ES, Wang EBK, Park KE, Espinosa ML, Duvic M, Kim YH, Horwitz S. Clinical and Pathological Characteristics and Outcomes Among Patients With Subcutaneous Panniculitis-like T-Cell Lymphoma and Related Adipotropic Lymphoproliferative Disorders. JAMA Dermatol. 2022 Oct 1;158(10):1167-1174. doi: 10.1001/jamadermatol.2022.3347.
6. LeWitt TM, Walker CJ, Espinosa ML, Chung C, Zhou XA, Guitart J. Cutaneous T-cell lymphoma and pregnancy: Great uncertainty and an appeal for prospective clinical research. J Am Acad Dermatol. 2022 Oct;87(4):856-858. doi: 10.1016/j.jaad.2021.10.041.
7. Ayasse MT, Ahmed A, Espinosa ML, Walker CJ, Yousaf M, Thyssen JP, Silverberg JI. What are the highest yielding search strategy terms for systematic reviews in atopic dermatitis? A systematic review. Arch Dermatol Res. 2021 Nov;313(9):737-750. doi: 10.1007/s00403-020-02165-z.
8. Walker CJ, Martinez-Escala ME, Tan TL, Espinosa ML, Guitart J. High incidence of adnexotropism in cytotoxic cutaneous lymphomas. J Cutan Pathol. 2021 Oct;48(10):1231-1238. doi: 10.1111/cup.14017.
9. Espinosa ML, Abad C, Kurtzman Y, Abdulla FR. Dermatologic Toxicities of Targeted Therapy and Immunotherapy in Head and Neck Cancers. Front Oncol. 2021 May 27. Doi:10.3389/fonc.2021.605941.
10. Walker CJ, Espinosa ML, Mehta-Shah N, Pro B, Guitart J, Kuzel T. Clinical Trial of High-Dose Pegylated-Interferon-Alfa-2b Combined With Phototherapy in Advanced Stage Mycosis Fungoides. J Drugs Dermatol. 2021 Mar 1;20(3):349-350. doi: 10.36849/JDD.5756.
11. Ayasse M, Ahmed A, McCullum C, Espinosa ML, Paller AS, Silverberg JI. Vaccines do not cause atopic dermatitis: A systematic review and meta-analysis. Vaccine. 2021 Mar 26;39(13):1805-1811. doi: 10.1016/j.vaccine.2021.02.036.
12. Jothishankar B, Espinosa ML, Zain J, Parekh V, Di Raimondo C, Abdulla F. Complete response to romidepsin as monotherapy in treatment-resistant subcutaneous panniculitis-like T-cell lymphoma. JAAD Case Rep. 2020 Oct 7;6(12):1245-1247. doi: 10.1016/j.jdcr.2020.09.018.
13. Espinosa ML, Nguyen MT, Aguirre AS, Martinez-Escala ME, Kim J, Walker CJ, Pontes DS, Silverberg JI, Choi J, Pro B, Pincus LB, Guitart J, Zhou XA. Progression of cutaneous T-cell lymphoma after dupilumab: Case review of 7 patients. J Am Acad Dermatol. 2020 Jul;83(1):197-199. doi: 10.1016/j.jaad.2020.03.050.
14. Espinosa ML, Tannenbaum AM, Kilaru M, Stevens J, Siegler M, Howell MD, Parker WF. Bundled Consent in US Intensive Care Units. Am J Crit Care. 2020 May 1;29(3):e44-e51. doi: 10.4037/ajcc2020502.
15. Espinosa ML, Lio P. Dermatologic Disparities: Essential Considerations in Patient Care. Practical Dermatology. 2019 April.
16. Espinosa ML, Lio P. Skin and disparity issues that affect patients of color. Dermatology Times. 2019 Feb 6.
PRESENTATIONS
1. Espinosa ML, Ago F, Matthews N. Granulomatous syphilis masquerading as folliculitis. Poster presentation at Henry Ford Medical Education Research Day in Detroit, MI on May 3, 2024.
2. Espinosa ML, Yaldo M, Konda S, Rambhatla P. Reactive Infectious Mucocutaneous Eruption (RIME) from COVID-19 infection. Poster presentation at the Michigan Dermatology Society conference in Detroit, MI on October 4, 2023.
3. Espinosa ML. Latinx Dermatology: why we need YOU in Dermatology. Oral presentation at the Latino Medical Student Association National Conference in Atlanta, Georgia on September 16, 2023.
4. Espinosa ML. The journey into dermatology, critical strategies for success sponsored by L’oreal Dermatological Beaty. Panelist at the Latino Medical Student Association National Conference in Atlanta, Georgia on September 15, 2023.
5. Espinosa ML. Resident perspectives. Panelist at the American Academy of Dermatology Diversity Champion Workshop in Chicago, IL on 9/2022).
6. Espinosa ML. Different appearance of skin conditions across skin types. Oral presentation at the Henry Ford Health System summer pipeline program in Detroit, MI on 7/27/2021.
7. Espinosa ML, Nguyen MT, Agirre A, Martinez-Escala E, Walker CJ, Pontes D, Silverberg JI, Choi J, Pro B, Pincus LB, Guitart J. Progression of Cutaneous T-cell lymphoma after dupilumab: Case review of 6 patients. Accepted for 2020 American Academy of Dermatology conference but canceled due to COVID-19 pandemic, Denver, CO.
8. Espinosa ML, Nguyen MT, Agirre A, Martinez-Escala E, Walker CJ, Pontes D, Silverberg JI, Choi J, Pro B, Pincus LB, Guitart J. Progression of Cutaneous T-cell lymphoma after dupilumab: Case review of 6 patients. Oral presentation at 4th Annual World Congress of Cutaneous Lymphomas, Barcelona, Spain on February 12, 2020.
9. Espinosa ML, Mhlaba J, Walker CJ, Guitart J. (2020) Morphology of mycosis fungoides/ Sézary syndrome in patients with Fitzpatrick skin type III-VI: retrospective review of patient photographs from a single center cutaneous T-cell lymphoma clinic. Accepted for Skin of Color society conference but cancelled due to COVID-19; Denver, CO.
10. Espinosa ML, Lio P. Dermatologic Disparities: Essential Considerations in Patient Care. Oral presentation at Medical Organization for Latino Advancement (MOLA) conference; Chicago, IL in 2019.
11. Espinosa ML, Tannenbaum A, Kilaru M, Stevens J, Siegler M, Howell MD, Parker WF. Bundled Consent in U.S. Intensive Care Units (ICUs). Poster presentation at American Thoracic Society Conference in San Diego, CA on May 18, 2018.
12. Espinosa ML, Szutenbach S, Adley K, Balachandran J. Factors Influencing Consent Rates in a Sleep Medicine Randomized Control Trial. Poster presentation at Chicago Academic Research Symposium in Chicago, IL in 2015.
2024 Henry Ford Medical Education Research Day Second place in case report category for “Granulomatous syphilis masquerading as folliculitis”.
2023 Global Partnerships for Education and Care Program Grant from the International League of Dermatological Societies
Aided in obtaining grant for Henry Ford Dermatology residents to collaborate with a dermatology program in Bogotá, Colombia for an international exchange program. Traveled to Colombia in March 2025 to engage in this two-week elective.
2015 Mortar Board National Honor Society Inductee [The Ohio State University] Honor society recognizing outstanding achievement in the liberal arts and sciences.
2012-2016 Distinction Morrill Scholarship [The Ohio State University] Full-tuition scholarship awarded based on academic and extracurricular achievement.
Maria Espinosa, MD
Dr. Espinosa is an academically accomplished dermatologist that specializes in medical, surgical, and cosmetic dermatology, caring for patients of all ages. Graduating magna cum laude from Ohio State University with a Bachelor of Science in Neuroscience, she went on to complete a research year in Cutaneous Lymphoma at Northwestern University, Department of Dermatology. She then earned her medical degree from the University of Chicago, Pritzker School of Medicine. Her commitment to excellence continued during her transitional year and dermatology residency at Henry Ford Health, Medicine Department of Dermatology where she served as chief resident.
Dr. Espinosa’s clinical interests include general and complex medical conditions such as annual skin cancer screening, acne, rosacea, eczema, psoriasis as well as more complex autoimmune disorders. Dr. Espinosa is also skilled in performing surgical procedures on skin cancers and cysts, and cosmetic enhancements like Botox, laser treatments, and chemical peels.
Dr. Espinosa values creating personalized treatment plans and ensuring each patient feels heard and cared for. She is fluent in English and Spanish, allowing her to connect with a diverse group of patients. Her goal is to build lasting relationships and help patients achieve healthy, confident skin.
Outside of work, Dr. Espinosa loves spending time with her husband, Kevin, and their mini Goldendoodle, Louie.
1. Singh I, Espinosa ML, Lim HW, Mohammad TF. A review of therapies for hyperpigmentation modulating the synthesis of eumelanin to pheomelanin. Archives of Dermatology. Arch Dermatol Res. 2024 Oct 9;316(9):668. doi: 10.1007/s00403-024-03411-4.
2. LeWitt TM, Walker CJ, Espinosa ML, Chung C, Zhou XA, Guitart J. Reply to letter to the editor (Manuscript # JAAD-D-22-03011R1). J Am Acad Dermatol. 2023 Jul;89(1):e67. doi: 10.1016/j.jaad.2023.02.056.
3. Nguyen M, LeWitt T, Pang Y, Bagnowski K, Espinosa ML, Choi J, Guitart J, Liszewski W, Zhou XA. Lifestyle, demographic and Skindex measures associated with cutaneous T-cell lymphoma: a single institution cohort study. Arch Dermatol Res. 2023 Mar;315(2):275-278. doi: 10.1007/s00403-022-02360-0.
4. Chung C, Espinosa ML, Walker CJ, Choi J, Zhou XA, LeWitt T, Liszewski W, Guitart J. Acceleration of skin involvement may predict disease progression in early-stage mycosis fungoides: A retrospective cohort study. J Am Acad Dermatol. 2022 Nov;87(5):1140-1141. doi: 10.1016/j.jaad.2022.02.015.
5. Guitart J, Mangold AR, Martinez-Escala ME, Walker CJ, Comfere NI, Pulitzer M, Rieger KE, Torres-Cabala CA, Pincus LB, Kumar ES, Wang EBK, Park KE, Espinosa ML, Duvic M, Kim YH, Horwitz S. Clinical and Pathological Characteristics and Outcomes Among Patients With Subcutaneous Panniculitis-like T-Cell Lymphoma and Related Adipotropic Lymphoproliferative Disorders. JAMA Dermatol. 2022 Oct 1;158(10):1167-1174. doi: 10.1001/jamadermatol.2022.3347.
6. LeWitt TM, Walker CJ, Espinosa ML, Chung C, Zhou XA, Guitart J. Cutaneous T-cell lymphoma and pregnancy: Great uncertainty and an appeal for prospective clinical research. J Am Acad Dermatol. 2022 Oct;87(4):856-858. doi: 10.1016/j.jaad.2021.10.041.
7. Ayasse MT, Ahmed A, Espinosa ML, Walker CJ, Yousaf M, Thyssen JP, Silverberg JI. What are the highest yielding search strategy terms for systematic reviews in atopic dermatitis? A systematic review. Arch Dermatol Res. 2021 Nov;313(9):737-750. doi: 10.1007/s00403-020-02165-z.
8. Walker CJ, Martinez-Escala ME, Tan TL, Espinosa ML, Guitart J. High incidence of adnexotropism in cytotoxic cutaneous lymphomas. J Cutan Pathol. 2021 Oct;48(10):1231-1238. doi: 10.1111/cup.14017.
9. Espinosa ML, Abad C, Kurtzman Y, Abdulla FR. Dermatologic Toxicities of Targeted Therapy and Immunotherapy in Head and Neck Cancers. Front Oncol. 2021 May 27. Doi:10.3389/fonc.2021.605941.
10. Walker CJ, Espinosa ML, Mehta-Shah N, Pro B, Guitart J, Kuzel T. Clinical Trial of High-Dose Pegylated-Interferon-Alfa-2b Combined With Phototherapy in Advanced Stage Mycosis Fungoides. J Drugs Dermatol. 2021 Mar 1;20(3):349-350. doi: 10.36849/JDD.5756.
11. Ayasse M, Ahmed A, McCullum C, Espinosa ML, Paller AS, Silverberg JI. Vaccines do not cause atopic dermatitis: A systematic review and meta-analysis. Vaccine. 2021 Mar 26;39(13):1805-1811. doi: 10.1016/j.vaccine.2021.02.036.
12. Jothishankar B, Espinosa ML, Zain J, Parekh V, Di Raimondo C, Abdulla F. Complete response to romidepsin as monotherapy in treatment-resistant subcutaneous panniculitis-like T-cell lymphoma. JAAD Case Rep. 2020 Oct 7;6(12):1245-1247. doi: 10.1016/j.jdcr.2020.09.018.
13. Espinosa ML, Nguyen MT, Aguirre AS, Martinez-Escala ME, Kim J, Walker CJ, Pontes DS, Silverberg JI, Choi J, Pro B, Pincus LB, Guitart J, Zhou XA. Progression of cutaneous T-cell lymphoma after dupilumab: Case review of 7 patients. J Am Acad Dermatol. 2020 Jul;83(1):197-199. doi: 10.1016/j.jaad.2020.03.050.
14. Espinosa ML, Tannenbaum AM, Kilaru M, Stevens J, Siegler M, Howell MD, Parker WF. Bundled Consent in US Intensive Care Units. Am J Crit Care. 2020 May 1;29(3):e44-e51. doi: 10.4037/ajcc2020502.
15. Espinosa ML, Lio P. Dermatologic Disparities: Essential Considerations in Patient Care. Practical Dermatology. 2019 April.
16. Espinosa ML, Lio P. Skin and disparity issues that affect patients of color. Dermatology Times. 2019 Feb 6.
PRESENTATIONS
1. Espinosa ML, Ago F, Matthews N. Granulomatous syphilis masquerading as folliculitis. Poster presentation at Henry Ford Medical Education Research Day in Detroit, MI on May 3, 2024.
2. Espinosa ML, Yaldo M, Konda S, Rambhatla P. Reactive Infectious Mucocutaneous Eruption (RIME) from COVID-19 infection. Poster presentation at the Michigan Dermatology Society conference in Detroit, MI on October 4, 2023.
3. Espinosa ML. Latinx Dermatology: why we need YOU in Dermatology. Oral presentation at the Latino Medical Student Association National Conference in Atlanta, Georgia on September 16, 2023.
4. Espinosa ML. The journey into dermatology, critical strategies for success sponsored by L’oreal Dermatological Beaty. Panelist at the Latino Medical Student Association National Conference in Atlanta, Georgia on September 15, 2023.
5. Espinosa ML. Resident perspectives. Panelist at the American Academy of Dermatology Diversity Champion Workshop in Chicago, IL on 9/2022).
6. Espinosa ML. Different appearance of skin conditions across skin types. Oral presentation at the Henry Ford Health System summer pipeline program in Detroit, MI on 7/27/2021.
7. Espinosa ML, Nguyen MT, Agirre A, Martinez-Escala E, Walker CJ, Pontes D, Silverberg JI, Choi J, Pro B, Pincus LB, Guitart J. Progression of Cutaneous T-cell lymphoma after dupilumab: Case review of 6 patients. Accepted for 2020 American Academy of Dermatology conference but canceled due to COVID-19 pandemic, Denver, CO.
8. Espinosa ML, Nguyen MT, Agirre A, Martinez-Escala E, Walker CJ, Pontes D, Silverberg JI, Choi J, Pro B, Pincus LB, Guitart J. Progression of Cutaneous T-cell lymphoma after dupilumab: Case review of 6 patients. Oral presentation at 4th Annual World Congress of Cutaneous Lymphomas, Barcelona, Spain on February 12, 2020.
9. Espinosa ML, Mhlaba J, Walker CJ, Guitart J. (2020) Morphology of mycosis fungoides/ Sézary syndrome in patients with Fitzpatrick skin type III-VI: retrospective review of patient photographs from a single center cutaneous T-cell lymphoma clinic. Accepted for Skin of Color society conference but cancelled due to COVID-19; Denver, CO.
10. Espinosa ML, Lio P. Dermatologic Disparities: Essential Considerations in Patient Care. Oral presentation at Medical Organization for Latino Advancement (MOLA) conference; Chicago, IL in 2019.
11. Espinosa ML, Tannenbaum A, Kilaru M, Stevens J, Siegler M, Howell MD, Parker WF. Bundled Consent in U.S. Intensive Care Units (ICUs). Poster presentation at American Thoracic Society Conference in San Diego, CA on May 18, 2018.
12. Espinosa ML, Szutenbach S, Adley K, Balachandran J. Factors Influencing Consent Rates in a Sleep Medicine Randomized Control Trial. Poster presentation at Chicago Academic Research Symposium in Chicago, IL in 2015.
2024 Henry Ford Medical Education Research Day Second place in case report category for “Granulomatous syphilis masquerading as folliculitis”.
2023 Global Partnerships for Education and Care Program Grant from the International League of Dermatological Societies
Aided in obtaining grant for Henry Ford Dermatology residents to collaborate with a dermatology program in Bogotá, Colombia for an international exchange program. Traveled to Colombia in March 2025 to engage in this two-week elective.
2015 Mortar Board National Honor Society Inductee [The Ohio State University] Honor society recognizing outstanding achievement in the liberal arts and sciences.
2012-2016 Distinction Morrill Scholarship [The Ohio State University] Full-tuition scholarship awarded based on academic and extracurricular achievement.
Education and Training